US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist
  • 21.160
  • +0.920+4.55%
Close Jul 22 16:00 ET
  • 21.250
  • +0.090+0.43%
Post 17:52 ET
319.21MMarket Cap-3785P/E (TTM)

Jasper Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jasper Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.03

+36.42%
Analyst Rating

Strong Buy

Jul 8, 2024

Jasper Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Jasper Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 14 13:55 ET

  • Jasper Therapeutics | 10-K: Annual report

    Mar 5 16:04 ET

  • Jasper Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 09:18 ET

  • Jasper Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 8, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg